publication venue for
- Epigenetic and genetic risk of Alzheimer disease from autopsied brains in two ethnic groups.. 148:-. 2024
- Neuropathologically directed profiling of PRNP somatic and germline variants in sporadic human prion disease.. 148:-. 2024
- Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer's Coordinating Center database.. 147:-. 2024
- Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer's disease.. 147:-. 2024
- Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies.. 147:-. 2024
- LATE-NC staging in routine neuropathologic diagnosis: an update.. 145:159-173. 2022
- Tuberous sclerosis complex is associated with a novel human tauopathy.. 145:1-12. 2022
- RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation.. 145:29-48. 2022
- Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo.. 144:881-910. 2022
- Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI.. 144:1117-1125. 2022
- Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts.. 144:27-44. 2022
- Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice.. 143:663-685. 2022
- Correction to: Apolipoprotein E regulates lipid metabolism and α‑synuclein pathology in human iPSC‑derived cerebral organoids.. 143:119-121. 2022
- Genome-wide association study and functional validation implicates JADE1 in tauopathy.. 143:33-53. 2021
- Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids.. 142:807-825. 2021
- Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease.. 142:689-706. 2021
- Cryo-EM structures of tau filaments from Alzheimer's disease with PET ligand APN-1607.. 141:697-708. 2021
- Latent trait modeling of tau neuropathology in progressive supranuclear palsy.. 141:667-680. 2021
- Lack of evidence supporting a role for DPP6 sequence variants in Alzheimer's disease in the European American population.. 141:623-624. 2021
- Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions.. 141:359-381. 2021
- The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer's disease.. 141:631-650. 2021
- Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy.. 140:659-674. 2020
- TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis.. 140:513-534. 2020
- Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.. 139:959-962. 2020
- Overlapping genetic architecture between Parkinson disease and melanoma.. 139:347-364. 2019
- The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion.. 139:45-61. 2019
- C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy.. 138:795-811. 2019
- A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.. 138:237-250. 2019
- Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypes.. 138:167-169. 2019
- Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease.. 137:209-226. 2018
- Rebuttal to Drs. Grinberg and Heinsen.. 136:-. 2018
- Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease.. 136:919-938. 2018
- Sex-specific genetic predictors of Alzheimer's disease biomarkers.. 136:857-872. 2018
- Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients.. 136:425-443. 2018
- Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits.. 134:749-767. 2017
- [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.. 134:619-628. 2017
- Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.. 133:839-856. 2017
- Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).. 133:705-715. 2017
- Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.. 132:197-211. 2016
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.. 131:925-33. 2016
- Inefficient induction and spread of seeded tau pathology in P301L mouse model of tauopathy suggests inherent physiological barriers to transmission.. 130:303-5. 2015
- Primary age-related tauopathy (PART): a common pathology associated with human aging.. 128:755-66. 2014
- Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice.. 127:645-65. 2014
- TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.. 127:407-18. 2014
- Anti-Aβ antibody target engagement: commentary regarding Watt et al. Acta Neuropathol 127:803-810 (2014).. 128:609-10. 2014
- Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy.. 126:39-50. 2013
- Alzheimer's pathogenesis: is there neuron-to-neuron propagation?. 121:589-95. 2011
- Morphometry of the human substantia nigra in ageing and Parkinson's disease.. 115:461-70. 2008
- Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.. 114:5-22. 2007
- Entorhinal cortex of aged subjects with Down's syndrome shows severe neuronal loss caused by neurofibrillary pathology.. 97:156-64. 1999